Similarly to previously, in the allergic rhinitis model (AR) and in β-lactoglobulin-induced food allergy, miRNA-146a showed anti-inflammatory potential by inhibiting the TLR4/TRAF6/NF-κB pathway [90,91]. Here, TRAF6 is linked to allergic rhinitis.